Elkerliek Ziekenhuis

At Elkerliek Ziekenhuis, clinical trials in cardiovascular diseases and nutritional and metabolic disorders focus on conditions such as atherosclerotic cardiovascular disease, heart failure, and obesity. These studies are exploring whether new medicines can better lower cardiovascular risk, improve symptom control, and reduce major heart-related events.

• Testing new therapies aimed at reducing major adverse cardiovascular events
• Evaluating treatments for heart failure with preserved or mildly reduced ejection fraction
• Studying options for patients with obesity and elevated cardiovascular risk

This research helps clarify how emerging treatments may improve long-term outcomes for people at high risk of heart and metabolic complications.

The site is also active in neoplasms research, with trials involving breast cancer, advanced non-small cell lung cancer, colorectal cancer, rectal cancer, esophagogastric cancer, and multiple myeloma. These studies are assessing new treatment strategies, treatment effectiveness, and ways to balance cancer control with tolerability.

• Comparing treatment approaches for metastatic colorectal cancer and locally advanced rectal cancer
• Evaluating endocrine-based strategies for hormone receptor-positive breast cancer
• Studying immunotherapy and chemotherapy options for advanced lung cancer and other solid tumors

These trials reflect a strong focus on improving outcomes while making cancer care more manageable for patients.

In obstetrics and gynecology, research at the hospital covers female urogenital diseases, pregnancy-related care, and reproductive physiology. Key studies address infertility and polycystic ovary syndrome, with the goal of improving the chances of conception and live birth.

• Assessing fertility treatments for infertile women
• Comparing approaches for ovulation induction in polycystic ovary syndrome
• Supporting better reproductive outcomes through treatment optimization

This work highlights practical efforts to improve family-planning care and reproductive success for women seen at Elkerliek Ziekenhuis.

Trials in hormonal diseases include research on hyperactive thyroid nodules and treatment choices for hyperthyroidism. The main aim is to compare options that may control symptoms effectively while reducing the chance of long-term thyroid problems.

• Comparing therapies for solitary autonomous thyroid nodules
• Studying outcomes linked to thyroid function preservation
• Evaluating treatment effectiveness and safety in thyroid disease

This area of research supports more personalized decisions for patients living with thyroid-related hormonal disorders.

The site contributes to nervous system diseases research through studies in ischemic stroke and transient ischemic attack. These trials are designed to assess whether preventive treatments can improve survival without new vascular events and support recovery in older, frail patients.

• Testing preventive strategies after stroke or transient ischemic attack
• Evaluating ways to reduce recurrent cardiovascular and cerebrovascular events
• Improving care for patients at high risk of future vascular complications

The research aims to strengthen secondary prevention and improve quality of life after a cerebrovascular event.

Beyond disease-specific studies, Elkerliek Ziekenhuis also participates in research on analytical and diagnostic techniques as well as surgical procedures. This includes work intended to improve diagnostic choices, refine treatment pathways, and make care more efficient for patients across several specialties.

• Comparing diagnostic approaches used in fertility assessment
• Investigating procedure-related choices that may improve patient comfort and care planning
• Supporting better clinical decision-making through applied health care research

These studies show a broader commitment to practical innovation across hospital-based clinical research.